Brief report · 30 Jun 2026
Conference abstractPublished 2 Nov 2015
Novel multiple type and wide spectral molecular targeted antitumor agents: Preparation and preclinical evaluation of IER5/Cdc25B targeted phospha sugar derivatives as well as attempts of computer aided drug designing
1Shizuoka University, Japan 2Hamamatsu University, Japan 3Numazu National College of Technology, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Novel multiple type and wide spectral low-molecular-weight molecular targeted antitumor agents of phospha sugar derivatives, which target IER5/Cdc25B and innovate in chemo-therapeutic treatments against various type of cancer cells, were investigated. We have developed novel synthetic methodologies for preparing phospha sugar derivatives, in which the oxygen atom in the hemiacetal ring of Haworth structure is replaced by a phosphorus moiety, and constructed their compound library, and then preclinical evaluations and mechanistic investigations have been carried out. Among the compound library of the phospha sugar derivatives, branched deoxybromo-phospha sugar derivatives (DBMPP and TBMPP) as well as some substituted phospha sugar analogues were found to exert novel, potential, and wide spectral antitumor activities by MTT in vitro evaluation method. The characterization and mechanism elucidation of these phospha sugar derivatives by flow cytometry and Western blotting showed that phospha sugars DBMPP and/or TBMPP enhanced the expression of cancer suppressors and suppressed the expression of cancer accelerators. Phospha sugar derivative TBMPP enhanced the expression of IER5 and then suppressed the expression of Cdc25B, which is the common and essential factor to act at the mitosis stage of tumor cell cycles. Therefore, phospha sugar derivatives might induce apoptosis at G2/M stage and inhibit the proliferation of various kinds of cancer cells. In vivo evaluation for TBMPP against K562 cells transplanted to a nude mouse implied successful cure of cancer. Based on the preclinical research and computer aided drug designing we are expecting that phospha sugars may be developed to be clinically useful novel antitumor agents.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mitsuji Yamashita”
- BylineArticles whose byline prints “Hiroko Hasegawa”
- BylineArticles whose byline prints “Michio Fujie”
- BylineArticles whose byline prints “Satoki Nakamura”
- BylineArticles whose byline prints “Reiko Makita”
- BylineArticles whose byline prints “Junko Yamashita”
- BylineArticles whose byline prints “Tatsuo Oshikawa”
- BylineArticles whose byline prints “Mitsuru Kondo”
